Xiaoman Wang

Xiaoman Wang is a Ph.D. candidate from Peking Union Medical College & Chinese Academy of Medical Science, Beijing, China. Her current research focuses on integrating drug perturbation data and clinical cohort data to systematically evaluate potential compounds that boost immunotherapy blockade(ICB) responses. She also helps in developing a deep learning algorithm (DeepImmune) to identify a compressed representation of immunological factors that predict ICB response.